Associazione Nazionale Medici Cardiologi Ospedalieri

congress.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
WHEN 4 MINUTES CAN CHANGE A LIFE FOREVER. A CASE OF VASOSPASTIC ANGINA WITH POLYMORPHIC VENTRICULAR ARRHYTHMIA.
Anno:
2026
Background Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) is a challenging clinical scenario because of its heterogeneous aetiologies. Among the clinical conditions considered causes of MINOCA, epicardial coronary artery spasm (variant angina, Prinzmetal angina) should be considered, especially when symptoms occur at rest. Abstract Herein, we describe a case…
Leggi di più
PREDICTORS OF MORTALITY IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE TREATED WITH AN EARLY AND ACCELERATED MANAGEMENT STRATEGY (INSIGHTS FROM FIL-AHF STUDY)
Anno:
2026
Introduction Acute decompensated heart failure (ADHF) remains a leading cause of hospitalization and mortality worldwide despite therapeutic advances. Early identification of patients at increased risk of adverse outcomes is crucial to improve clinical decision-making and optimize management strategies. Although early and accelerated treatment approaches may enhance hemodynamic stabilization, their…
Leggi di più
EFFECTS OF TYPE 2 SODIUM GLUCOSE COTRANSPORTER INHIBITORS ON RENAL FUNCTION AND RENAL RESISTANCE INDEX
Anno:
2026
Background. Type 2 sodium glucose cotransporter inhibitors (SGLT2i) have demonstrated cardiorenal protection in patients affected by type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD) and chronic heart failure (CHF). Among the mechanisms underlying this benefit, there is the possible restoration of tubuloglomerular, which contrasts glomerular hyperfiltration and the…
Leggi di più
PONTE SC-SCA REGISTRY: BASELINE CHARACTERISTICS OF PATIENTS WITH HEART FAILURE
Anno:
2026
Background & Study Aim. The observational PONTE SC/SCA registry was designed to evaluate the effectiveness of integrated hospital-to-community care pathways for patients with heart failure (HF) or those recently hospitalized for acute coronary syndrome (ACS). This study aimed to describe the baseline characteristics of patients with HF enrolled in…
Leggi di più
DOSE OPTIMIZATION TRENDS OF THE FOUR PILLARS OF THERAPY IN HFREF: DATA FROM THE PONTE SC-SCA REGISTRY
Anno:
2026
Background & Study Aim. In patients with heart failure with reduced ejection fraction (HFrEF), the use of four main pharmacological classes is currently recommended: angiotensin receptor–neprilysin inhibitors (ARNI), preferred over angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB), beta-blockers, mineralocorticoid receptor antagonists (MRA), and sodium–glucose co-transporter 2 inhibitors…
Leggi di più
OPTIMIZATION OF MEDICAL THERAPY IN PATIENTS WITH HFMREF AND HFPEF: DATA FROM THE PONTE SC-SCA REGISTRY
Anno:
2026
Background & Study Aim. In recent years, significant progress has been made not only in the treatment of heart failure with reduced ejection fraction (HFrEF) but also in patients with mildly reduced (HFmrEF) and preserved ejection fraction (HFpEF). This study aimed to evaluate the management of HFmrEF and HFpEF…
Leggi di più
SAFETY OF EARLY AND ACCELERATED EVIDENCE BASED PHARMACOLOGICAL THERAPY FOLLOWING ACUTE DECOMPENSATED HEART FAILURE (THE FIL-AHF STUDY)
Anno:
2026
Introduction Growing evidence supports early and intensified therapy during hospitalization for acute decompensated heart failure (ADHF) to reduce cardiovascular morbidity and mortality across the entire spectrum of ejection fraction (EF). Trials such as EMPULSE and TRANSITION have demonstrated that early initiation of empagliflozin and sacubitril/valsartan in hospitalized patients with…
Leggi di più
HEART AND SELF-ESTEEM: NURSE-LED OPPORTUNISTIC CARDIOVASCULAR PREVENTION IN AESTHETIC MEDICINE CLINICS
Anno:
2026
Aesthetic medicine clinics attract a heterogeneous population seeking wellbeing, improved body image and greater self-esteem. Many of these individuals, often adults aged 30–65 years, present unrecognized or inadequately managed cardiovascular risk factors and rarely access conventional cardiology pathways spontaneously, making this setting an unconventional gateway of extraordinary potential for…
Leggi di più
SYNCOPE WITHOUT PRODROMES DURING FEVER IN TYPE 1-INDUCED BRUDAGA SYNDROME PATIENT: LOOKS CAN BE DECEIVING
Anno:
2026
Case presentation: A 53‐year‐old man, with no family history of sudden cardiac death (SCD), was admitted to the Emergency Department for transient of loss consciousness (TLOC) and facial trauma. The TLOC occurred at rest, in an upright position, without prodromes and/or specific triggers. At admission, the body temperature was…
Leggi di più
CHANNELOPATHY OR CARDIOMYOPATHY? PREVENTION OF SUDDEN CARDIAC DEATH IN A PATIENT WITH BRUGADA SYNDROME AND MITRAL ANNULAR DISJUNCTION (MAD)
Anno:
2026
A 34-year-old woman with a known spontaneous type 1 Brugada ECG pattern presented to the emergency department after a syncopal episode. Her medical history included a likely pathogenic SCN5A gene variant (with both her father and son affected) and a family history of sudden cardiac death. She was admitted…
Leggi di più